Has drug price reform already stalled? How far has tech come in medicine? And should there be an app for that?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Lev Facher joins us to explain how the latest twist in Congress could imperil a bipartisan push to lower drug costs. Then, Baylor medical ethicist Stephanie Morain stops by to explain why a new crop of apps to match cancer patients with clinical trials comes with some serious concerns. Finally, STAT’s Casey Ross dials in to talk about how the giants of tech are making inroads in health and medicine.

For more on what we cover, here’s the news from Washington; here’s the story of a clinical trial app that failed; and here’s more on the people to watch at big tech.

advertisement

We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email readoutloud@statnews.com.


Interested in sponsoring a future episode of “The Readout LOUD”? Email us at marketing@statnews.com.

Leave a Comment

Please enter your name.
Please enter a comment.

Your daily dose of news in health and medicine

Privacy Policy